Zai Lab (ZLAB) Free Cash Flow (2018 - 2026)
Zai Lab (ZLAB) posted quarterly Free Cash Flow of -$13.1 million for Q1 2026, up 79.27% year-on-year from -$7.3 million in Q1 2025, and up 50.91% on a QoQ basis from -$26.7 million in Q4 2025.
Zai Lab (ZLAB) Free Cash Flow (2018 - 2026) Analysis & Trends
Zai Lab (ZLAB) has reported Free Cash Flow for 9 consecutive years, with -$13.1 million the latest figure, recorded in Q1 2026.
- Quarterly Free Cash Flow rose 79.27% year-over-year to -$13.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$108.8 million (up 43.55% YoY) and the FY2025 annual result came in at -$158.9 million, up 27.95% from the prior year.
- Free Cash Flow climbed to -$13.1 million in Q1 2026 per ZLAB's latest filing, from -$26.7 million in the prior quarter.
- Over the last five years, Free Cash Flow for ZLAB reached as high as -$13.1 million in Q1 2026 and fell as low as -$133.0 million in Q3 2022.
- A 5-year average of -$58.2 million and a median of -$57.0 million in 2023 frame the typical range for Free Cash Flow.
- Annual changes were most pronounced in 2023 — Free Cash Flow soared 86.69% — and 2024, when it slumped 285.55%.
- Year by year, Free Cash Flow stood at -$113.7 million in 2022, then surged by 86.69% to -$15.1 million in 2023, then sank by 285.55% to -$58.4 million in 2024, then soared by 54.26% to -$26.7 million in 2025, then soared by 50.91% to -$13.1 million in 2026.
- According to Business Quant data, Free Cash Flow over the past three periods registered -$13.1 million, -$26.7 million, and -$35.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.58 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 158.09 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.29 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 848.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.95 Mn |
| 10 | Zai Lab | 22.02 Bn | 22.02 Bn | 61.30 Mn | -13.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13.11 Mn |
| Mar 31, 2026 | -13.11 Mn |
| Dec 31, 2025 | -26.70 Mn |
| Dec 31, 2025 | -26.70 Mn |
| Sep 30, 2025 | -35.05 Mn |
| Sep 30, 2025 | -35.05 Mn |
| Jun 30, 2025 | -33.91 Mn |
| Jun 30, 2025 | -33.91 Mn |
| Mar 31, 2025 | -63.23 Mn |
| Mar 31, 2025 | -63.23 Mn |
| Dec 31, 2024 | -58.37 Mn |
| Dec 31, 2024 | -58.37 Mn |
| Sep 30, 2024 | -28.16 Mn |
| Sep 30, 2024 | -28.16 Mn |
| Jun 30, 2024 | -42.91 Mn |
| Jun 30, 2024 | -42.91 Mn |
| Mar 31, 2024 | -91.08 Mn |
| Mar 31, 2024 | -91.08 Mn |
| Dec 31, 2023 | -15.14 Mn |
| Dec 31, 2023 | -15.14 Mn |